UPenn HIV Grand Rounds - Home Page

 

Jointly Provieded by: Penn Medicine and ViralEd, Inc.
 

Live Series Schedule

About the Program

Program Overview

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.

Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access. 

Back to Top

Target Audience

This program has been designed for Family Medicine, Neurology, Obstetrics and Gynecology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease.

Back to Top

Commercial Support Acknowledgement

HIV Grand Rounds is supported by independent educational grants from  ViiV Healthcare, Janssen Therapeutics, Gilead Sciences, Inc. and Merck & Co.

Back to Top

Learning Objectives

After completing this activity, participants should be better able to:

  • Describe how to apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients rapidly into care
  • Discuss how to individualize ARV therapy for the treatment-naïve and treatment-experienced patients to support adherence and patient satisfaction
  • Describe how to manage various patient populations, such as the aging patient with HIV infection, including issues associated with cardiovascular and bone disease, PWIDs and underserved populations
  • Discuss the basic science concepts involved with HIV and be able to apply those concepts to HIV therapeutics and other issues involved in HIV patient care and HIV prevention
Back to Top

Current Session Learning Objectives

After completing this activity, participants should be better able to:

  • Discuss advantages and disadvantages of the use of bnAbs for HIV immunoprophylaxis
  • Describe the pharmacokinetic and virus neutralization parameters that determine the effectiveness of antibodies for prevention
  • Describe future strategies for bnAbs as a tool for HIV prevention
Back to Top

Course Directors

Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania

Katherine Bar, MD
Assistant Professor
Department of Medicine
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania

Florence Momplaisir, MD, MSHP, FACP
Assistant Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Next Session and Participation Information

The Next Presentation of HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania will be:

Date: May 23, 2024 (Click to View On-Demand)

Faculty: Ian Frank, MD

Topic: bnAbs for HIV Prevention - Do They Have a Role as Long-Acting PrEP

Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand

  • Delivered via webinar directly to you  and/or your clinic
  • You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
  • Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device

If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.

Back to Top

Live Session Topics and Speakers


January 25, 2024

The Top Ten Publications in HIV Medicine in 2023

Ian Frank, MD

Click HERE to View On-Demand


February 1, 2024

Pharmacy-Based Approaches to Improving HIV and Substance Use Related Harms in High-Risk Communities

Natalie Crawford, PhD

Click HERE to View On-Demand


February 8, 2024

Improving the Use and Effectiveness of Treatments for Tobacco Use among People with HIV

Robert Schnoll, PhD

Click HERE to View On-Demand


February 22, 2024

Meeting you where you’re at: Innovating the delivery of HIV self-testing and PrEP care in Philadelphia

Cedric Bien-Gund, MD

Click HERE to View On-Demand


February 29, 2024

Implementation Science to End the HIV Epidemic: How rapid, how relevant, & how rigorous?

Sheree Schwartz, PhD

Click HERE to View On-Demand


March 14, 2024

A case-based tour through treating Non-tuberculous Mycobacteria infections

Peter Liu, MD

Click HERE to View On-Demand


March 28, 2024

Impact of antiretrovirals in pregnancy: a holistic view

Shahin Lockman, MD

Click HERE to View On-Demand


April 4, 2024

Highlights from CROI 2024, Part II: Prevention and Coinfections

Ian Frank, MD

Click HERE to View On-Demand Program


April 11, 2024

Systems Vaccinology

Bali Pulendran, PhD

Click HERE to View On-Demand


April 18, 2024

Understanding suicide risk among people with HIV: Intervention Opportunities

Lily A. Brown, PhD

Click HERE to View On-Demand


April 25, 2024

Sexually Transmitted Infections in Vulnerable Populations

Christina Muzny, MD

Click HERE to View On-Demand


May 9, 2024

Development of Highly Networked T cell Vaccines for HIV

Gaurav Gaiha, MD, DPhil

Click HERE to View On-Demand


May 16, 2024

Innovations in HIV Prevention, Treatment, and Comorbidity Management: Clinical Insights and Cases

Antonio E. Urbina, MD

Click HERE to View On-Demand


May 23, 2024

bnAbs for HIV Prevention - Do They Have a Role as Long-Acting PrEP

Ian Frank, MD

Click HERE to View On-Demand


May 30, 2024

How Do Health Insurance Expansions Affect Disparities in HIV Prevention and Treatment?

Aparna Soni, PhD

Click HERE to Register

 

 

 


 

TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW:
 

 

 

 

Back to Top

 

Hardware/Software Notice

You will need Internet to participate in this activity.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Penn Medicine and ViralEd. Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE)  have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Florence Momplaisir, MD (Program Co-Director)

Planning Committee Members:

  • ViralEd, Inc.: Brian Boyle, MD; Rick Gordon

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:


Ian Frank, MD (Program Co-director)

  • Advisor or Review Panel Member: Gilead; ViiV; Johnson & Johnson
  • Consulting Fee (All Relationships Ended): Gilead; Merck; Moderna 
  • Grant/Research Support Recipient (All Relationships Ended): Johnson & Johnson; Moderna; Pfizer; Sanofi Genzyme

Katherine Bar, MD (Program Co-director)

  • Consultant: Abbvie (Relationship Ended)
Back to Top

Discussion of Investigational and/or Off-label Use of Commercial Products and Devices

The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

   

    UPenn CME - 2019          VE Logo 2019           

 

Back to Top

 

Prepare to print

Share this page:

Get link code to this page     


Back to Top